HomeCompareJUNE vs MRK

JUNE vs MRK: Dividend Comparison 2026

JUNE yields 3.36% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $5.9K in total portfolio value
10 years
JUNE
JUNE
● Live price
3.36%
Share price
$59.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.8K
Annual income
$417.30
Full JUNE calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — JUNE vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJUNEMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JUNE + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JUNE pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JUNE
Annual income on $10K today (after 15% tax)
$285.71/yr
After 10yr DRIP, annual income (after tax)
$354.71/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $453.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JUNE + MRK for your $10,000?

JUNE: 50%MRK: 50%
100% MRK50/50100% JUNE
Portfolio after 10yr
$27.8K
Annual income
$683.80/yr
Blended yield
2.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

JUNE
No analyst data
Altman Z
673.0
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JUNE buys
0
MRK buys
0
No recent congressional trades found for JUNE or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJUNEMRK
Forward yield3.36%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$24.8K$30.7K
Annual income after 10y$417.30$950.29
Total dividends collected$3.8K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JUNE vs MRK ($10,000, DRIP)

YearJUNE PortfolioJUNE Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,036$336.13$11,192$351.54$156.00MRK
2$12,155$346.69$12,524$392.70$369.00MRK
3$13,363$356.87$14,015$438.65$652.00MRK
4$14,665$366.66$15,682$489.96$1.0KMRK
5$16,068$376.07$17,547$547.23$1.5KMRK
6$17,578$385.08$19,632$611.16$2.1KMRK
7$19,202$393.71$21,963$682.53$2.8KMRK
8$20,948$401.95$24,571$762.18$3.6KMRK
9$22,824$409.81$27,486$851.08$4.7KMRK
10$24,839$417.30$30,745$950.29$5.9KMRK

JUNE vs MRK: Complete Analysis 2026

JUNEStock

Junee Limited, through its subsidiary, OPS Interior Design Consultant Limited, provides interior design, fit-out, and maintenance services to residential and commercial clients in the interior design market in Hong Kong. Its interior design services comprise preliminary consulting services, conceptualizing clients design ideas with layout plans, and producing detailed design drawings; and fit-out work includes various activities making an interior space suitable for residential or commercial purposes. The company also provides a range of repair and maintenance services, including routine home condition upkeep services. The company was founded in 1998 and is based in Kowloon Bay, Hong Kong. Junee Limited operates as a subsidiary of OPS Holdings Limited.

Full JUNE Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this JUNE vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JUNE vs SCHDJUNE vs JEPIJUNE vs OJUNE vs KOJUNE vs MAINJUNE vs JNJJUNE vs ABBVJUNE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.